Current Research Studies
Cancer - ALTE15N2: Late Effects After High-Risk Neuroblastoma Study
What is the goal of this study?
This study looks at patients who have received treatment for high-risk neuroblastoma to establish which treatments are more successful and contain less side effects.
Who can join the study?
This study may be a good fit for individuals who:
- are 5 to 50 years old,
- have been enrolled on Children's Oncology Group neuroblastoma biology study ANBL00B1, and
- have been diagnosed with high-risk neuroblastoma.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.